Cancer Genetics and Epigenetics

Epigenetics deals with the study of heritable changes in gene, that does not include changes to the basic DNA arrangement — an adjustment in phenotype without an adjustment in genotype — which influences how cells read the genes.  The study of epigenetic modifications to the Cancer cells genome is called Cancer Epigenetics, that does not bring a change in the nucleotide sequence.

Risk expectation and prediction and Cancer prevention, growth counteractive action is also promising and encouraging areas of Epigenetics.

A high adequacy of demethylating agents were accounted for essentially in hematological malignancies in view of new conventions with low dose and long exposure, and their utilization is presently being striven for strong tumors.
During the cell’s transformation to Cancerous cell, Epigenetic modifications are also more important like genetic mutations. Their manipulation brings a great promising approach to for preventing, detecting and treatment of cancer

  • Heritable changes in gene
  • DNA arrangement
  • Nucleotide sequence

Related Conference of Cancer Genetics and Epigenetics

April 28-29, 2025

35th Experts Meet On Cancer Research & Therapy

Paris, France
May 26-27, 2025

15th World Congress on Breast Cancer

Rome, Italy
June 16-17, 2025

26th World Congress on Cancer Summit

Amsterdam, Netherlands
July 14-15, 2025

5th World Congress on Breast Cancer

Berlin, Germany
July 28-29, 2025

45th Euro Congress on Cancer Science & Therapy

Paris, France
August 18-19, 2025

6th Cancer Diagnostics & Treatment Conference

Rome, Italy
October 13-14, 2025

8th International Conference on Anti-Cancer Drugs & Therapies

Aix-en-Provence, France
October 20-21, 2025

21st International Conference on Cancer Research

Barcelona, Spain
November 24-25, 2025

43rd World Cancer Conference

Barcelona, Spain

Cancer Genetics and Epigenetics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in